Related Experiment Video
Updated: Nov 12, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery
Vance L Albaugh1, Tammy L Kindel2, Steven E Nissen3
1Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH, USA.
Insights
Metabolic surgery significantly benefits cardiovascular health, especially in patients with type 2 diabetes and obesity. Unlike other weight loss methods, bariatric surgery shows reproducible cardiovascular risk reduction, suggesting it may be the most effective treatment.
Area of Science:
- Integrates cardiology, endocrinology, and bariatric surgery research.
- Focuses on metabolic syndrome and cardiovascular disease (CVD) interplay.
Background:
- Cardiovascular disease (CVD) is a primary cause of death globally.
- Obesity and type 2 diabetes mellitus are escalating pandemics and major CVD risk factors.
- Previous nonsurgical obesity treatments have yielded limited CVD benefits.
Purpose of the Study:
- To evaluate the cardiovascular benefits of metabolic (bariatric) surgery.
- To compare surgical versus nonsurgical interventions for obesity and diabetes in relation to CVD risk reduction.
Main Methods:
- Review of retrospective and prospective cohort studies on metabolic surgery.
- Analysis of clinical trial data for both diabetes and obesity treatments.
- Assessment of CVD outcomes in patients undergoing bariatric procedures.
Main Results:
- Metabolic surgery is consistently associated with significant CVD benefits in observational studies.
- Recent diabetes trials show major cardiovascular benefits, contrasting with nonsurgical obesity treatments.
- Evidence suggests metabolic surgery is a highly effective CVD risk reduction strategy.
Conclusions:
- Metabolic surgery offers substantial and reproducible cardiovascular benefits.
- These benefits are likely mediated by both weight loss and weight loss-independent mechanisms.
- Metabolic surgery may represent the most effective approach for reducing cardiovascular risk in at-risk populations.
Abstract:
Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in developed countries, with worsening pandemics of type 2 diabetes mellitus and obesity as major cardiovascular (CV) risk factors. Clinical trials of nonsurgical obesity treatments have not shown benefits in CVD, although recent diabetes trials have demonstrated major CV benefits. In many retrospective and prospective cohort studies, however, metabolic (bariatric) surgery is associated with substantial and reproducible CVD benefits. Despite a lack of prospective, randomized clinical trials, data suggest metabolic surgery may be the most effective modality for CVD risk reduction, likely through weight loss and weight loss-independent mechanisms.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Coronary Artery Disease IV: Preventive Measures
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Atherosclerosis III: Management
Peripheral Artery Disease V: Postoperative Nursing Management
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

